Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis-Reference-Cited by-同舟云学术

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis

Published:2017-11-03 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Letouzé Eric^ORCID,Shinde Jayendra^ORCID,Renault Victor^ORCID,Couchy Gabrielle,Blanc Jean-Frédéric,Tubacher Emmanuel,Bayard Quentin,Bacq Delphine,Meyer Vincent,Semhoun Jérémy,Bioulac-Sage Paulette,Prévôt Sophie,Azoulay Daniel,Paradis Valérie,Imbeaud Sandrine^ORCID,Deleuze Jean-François,Zucman-Rossi Jessica^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01358-x.pdf

Reference52 articles.

1. Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15, 585–598 (2014).

2. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246–259 (2013).

3. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).

4. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013).

5. Polak, P. et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518, 360–364 (2015).

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations, substitutions, and selection: Linking mutagenic processes to cancer using evolutionary theory;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. The evolutionary theory of cancer: challenges and potential solutions;Nature Reviews Cancer;2024-09-10

3. Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era;Expert Review of Molecular Diagnostics;2024-08-28

4. Multiregion exome sequencing indicates a monoclonal origin of esophageal spindle‐cell squamous cell carcinoma;The Journal of Pathology;2024-07-18

5. Cancer burden: incorrect lifestyle or bad luck?;Minerva Medica;2024-06